Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, Double-blind, Active-Comparator-Controlled Clinical Study to Evaluate the Efficacy and Safety of Bomedemstat (MK- 3543) versus Hydroxyurea in Cytoreductive Therapy Naïve Essential Thrombocythemia Participants

Project: Research

Project Details

StatusActive
Effective start/end date9/12/24 → 8/12/29

Clinical Trial Phase

  • Phase III (a & b)